Standard Biotools (LAB) Current Deferred Revenue (2010 - 2026)
Standard Biotools (LAB) posted quarterly Current Deferred Revenue of $13.0 million for Q1 2026, up 1.81% year-over-year from $12.8 million in Q1 2025, and down 66.64% quarter-over-quarter from $38.9 million in Q4 2025.
Standard Biotools (LAB) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Current Deferred Revenue for 17 consecutive years, with $13.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 1.81% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $13.0 million (up 1.81% YoY), while the FY2025 annual figure was $38.9 million, down 9.31% from the prior year.
- Current Deferred Revenue declined to $13.0 million in Q1 2026 per LAB's latest filing, from $38.9 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $48.5 million in Q2 2024 and bottomed at $11.6 million in Q4 2023.
- Historically, Current Deferred Revenue has averaged $24.6 million across 5 years, with a median of $15.8 million in 2022.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue soared 310.45% — and 2025, when it sank 73.28%.
- Standard Biotools' Current Deferred Revenue stood at $14.6 million in 2022, then declined by 20.54% to $11.6 million in 2023, then jumped by 270.02% to $42.9 million in 2024, then dropped by 9.31% to $38.9 million in 2025, then tumbled by 66.64% to $13.0 million in 2026.
- Business Quant data shows LAB's Current Deferred Revenue at $13.0 million in Q1 2026, $38.9 million in Q4 2025, and $40.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.29 Mn |
| Mar 31, 2026 | 12.99 Mn |
| Dec 31, 2025 | 38.95 Mn |
| Sep 30, 2025 | 40.11 Mn |
| Jun 30, 2025 | 42.95 Mn |
| Mar 31, 2025 | 12.76 Mn |
| Dec 31, 2024 | 42.95 Mn |
| Sep 30, 2024 | 13.44 Mn |
| Jun 30, 2024 | 48.51 Mn |
| Mar 31, 2024 | 47.76 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 14.70 Mn |
| Jun 30, 2023 | 15.50 Mn |
| Mar 31, 2023 | 11.64 Mn |
| Dec 31, 2022 | 14.61 Mn |
| Sep 30, 2022 | 15.80 Mn |
| Jun 30, 2022 | 16.50 Mn |
| Mar 31, 2022 | 18.10 Mn |
| Dec 31, 2021 | 17.91 Mn |
| Sep 30, 2021 | 12.86 Mn |